STOCKHOLM, April 6, 2017 /PRNewswire/ --
Eurocine Vaccines expects results from the ongoing immunological analyses in June/July 2017. The samples presently being analyzed were collected during the clinical study on the nasal influenza vaccine candidate Immunose™ FLU, conducted in the current influenza season, 2016/2017.
"I am pleased that the progress of the immunological analyses has been somewhat faster than expected", said CSO Dr. Anna-Karin Maltais."
CONTACT:
CEO of Eurocine Vaccines AB
hans.arwidsson@eurocine-vaccines.com
+46-70-634-0171
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/eurocine-vaccines/r/eurocine-vaccines-expects-clinical-results-june-july-2017,c2234148
The following files are available for download:
| See press release |
